PATRICIA ROUNTREE: Open Payments
NPI 1326412032 · OPP, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$626 in 26 payments from 10 companies in 2025. Trend: 2023 $317 · 2024 $492 · 2025 $626
Food & beverage: $626
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $161 |
| GlaxoSmithKline, LLC. | 6 | $114 |
| AstraZeneca Pharmaceuticals LP | 3 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $64 |
| Novo Nordisk Inc | 2 | $54 |
| Lundbeck LLC | 1 | $24 |
| Abbott Laboratories | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $15 |
Products named: MOUNJARO, TRELEGY ELLIPTA, BREZTRI, CAPLYTA, Kerendia, REXULTI, Ozempic, Rybelsus.
Industry payments across AL — which companies pay providers there.
